Cefdinir Dispersible Tablets

Antibacterial effect It has a wide antibacterial spectrum against Gram-positive and Gram-negative bacteria, especially against Staphylococcus and Streptococcus among Gram-positive bacteria. It has stronger antibacterial activity than previous oral cephalosporins, and its mode of action is bactericidal. It is stable to β-lactamase produced by various bacteria, and also has excellent antibacterial activity against β-lactamase producing bacteria. The mechanism of action is to prevent the synthesis of bacterial cell walls. It has a strong affinity for penicillin binding protein (PBP) 1 (1a, 1bs), 2, and 3, but the active sites for different bacteria are different. Acute and chronic toxicity studies on cefdinir in animals such as rats and dogs have shown that cefdinir can be well tolerated. Cefdinir has not been found to be teratogenic or mutagenic.

The main ingredient is cefdinir. Chemical name: [6R-[6α, 7β(Z)]]-7-[[(2-amino-4-thiazolyl)-(oxime)acetyl]amino]-3-vinyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxyl Molecular weight: C14H13N5O5S2

This product is light yellow to yellow tablets.

No data yet

Disperse with water and take orally or swallow directly. The usual dose for adults is 100 mg (potency) once, three times a day. The usual dose for children is 9-18 mg (potency)/kg per day, taken orally three times. The dose can be increased or decreased according to age and symptoms.

Among the 13,715 patients treated with this product, 354 (2.58%) reported adverse reactions (including abnormal laboratory data). The main adverse reactions were gastrointestinal symptoms (110 cases, 0.80%), such as diarrhea or abdominal pain; skin symptoms (31 cases, 0.23%), such as rash or itching. The main laboratory data abnormalities included elevated alanine aminotransferase (126 cases, 0.92%) and aspartate aminotransferase (89 cases, 0.65%); eosinophilia (41 cases, 0.30%).

Patients with a history of shock should not use Cefdinir (Cefdinir Dispersible Tablets). Patients with a history of allergy to penicillin or cephalosporin should use with caution.

Precautions for children: The safety of medication for premature infants and newborns with low body weight has not been established. Precautions for pregnancy and lactation: The safety of medication during pregnancy has not been established. For pregnant women or women suspected of being pregnant, the pros and cons of medication should be weighed, and it can only be used when the benefits outweigh the risks. The pros and cons of medication for lactating women should be weighed, and it can only be used when the benefits outweigh the risks. Precautions for the elderly: Elderly patients should pay special attention to the following aspects when using this product, and adjust the dosage and dosing interval based on clinical observations of the patients: 1. Elderly patients may be prone to adverse reactions due to decreased physical function. 2. Elderly patients may have a tendency to bleed due to vitamin K deficiency.

Caution should be exercised when this product is used in combination with the following drugs.

Light-proof and sealed.

0.1g

24 months

Harbin Longshengbeiyao Biological Engineering Co., Ltd.

• Founded in:

  2003-08-15

• Address:

  Room 1512, Management Building, No. 368, Changjiang Road, Nangang Central District, Harbin Economic Development Zone

• Tax NO.:

  91230199749530695E

• Registered Funds:

  56.4 million yuan

• Website:

  Log in to view

• Email:

  Log in to view